A Mutant ataxin-3 fragment N-terminal to amino acid 190 disease-like transgenic mice

被引:41
作者
Gould, Veronica F. Colomer
Goti, Daniel
Pearce, Donna
Gonzalez, Guillenno A.
Gao, Hong
De Leon, Mario Bennudez
Jenkins, Nancy A.
Copeland, Neal G.
Ross, Christopher A.
Brown, Dale R.
机构
[1] Johns Hopkins Univ Hosp, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA
[2] Diag Grifols Reagents R&D Div, E-08150 Baracaldo, Spain
[3] Inst Mol & Cell Biol, Singapore 138673, Singapore
[4] Johns Hopkins Univ, Sch Med, Dept Neurosci, Dept Psychiat,Div Neurobiol, Baltimore, MD 21287 USA
[5] Johns Hopkins Univ, Sch Med, Dept Neurol, Dept Psychiat,Div Neurobiol, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
machado-joseph disease; spinocerebellar ataxia type 3; polyglutamine disease; ataxin-3; cleavage fragment; proteolysis; transgenic mouse;
D O I
10.1016/j.nbd.2007.06.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Machado-Joseph disease also called spinocerebellar ataxia type 3 (MJD/SCA3) is a hereditary and neurodegenerative movement disorder caused by ataxin-3 with a polyglutamine expansion (mutant ataxin-3). Neuronal loss in MJD/SCA3 is associated with a mutant ataxin-3 toxic fragment. Defining mutant ataxin-3 proteolytic site(s) could facilitate the identification of the corresponding enzyme(s). Previously, we reported a mutant ataxin-3 mjd1a fragment in the brain of transgenic mice (Q71) that contained epitopes C-terminal to amino acid 220. In this study, we generated and characterized neuroblastoma cells and transgenic mice expressing mutant ataxin-3 mjd1a lacking amino acids 190-220 (deltaQ71). Less deltaQ71 than Q71 fragments were detected in the cell but not mouse model. The transgenic mice developed an MJD/SCA3-like phenotype and their brain homogenates had a fragment containing epitopes C-terminal to amino acid 220. Our results support the toxic fragment hypothesis and narrow the mutant ataxin-3 cleavage site to the N-terminus of amino acid 190. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:362 / 369
页数:8
相关论文
共 58 条
[1]   Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3 [J].
Berke, SJS ;
Schmied, FAF ;
Brunt, ER ;
Ellerby, LM ;
Paulson, HL .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (04) :908-918
[2]   The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity [J].
Burnett, B ;
Li, FS ;
Pittman, RN .
HUMAN MOLECULAR GENETICS, 2003, 12 (23) :3195-3205
[3]   Purification of polyglutamine proteins [J].
Chow, Michelle K. M. ;
Ellisdon, Andrew M. ;
Cabrita, Lisa D. ;
Bottomley, Stephen P. .
AMYLOID, PRIONS, AND OTHER PROTEIN AGGREGATES, PT C, 2006, 413 :1-19
[4]  
Chow MKM, 2004, BIOCHEM BIOPH RES CO, V322, P387, DOI 10.1016/j.bbrc.2004.07.131
[5]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[6]   Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates [J].
Donaldson, KM ;
Li, W ;
Ching, KA ;
Batalov, S ;
Tsai, CC ;
Joazeiro, CAP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) :8892-8897
[7]   Ataxin-3 interactions with Rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis [J].
Doss-Pepe, EW ;
Stenroos, ES ;
Johnson, WG ;
Madura, K .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (18) :6469-6483
[8]   Spinocerebellar ataxia 3 and Machado-Joseph disease: Clinical, molecular, and neuropathological features [J].
Durr, A ;
Stevanin, G ;
Cancel, G ;
Duyckaerts, C ;
Abbas, N ;
Didierjean, O ;
Chneiweiss, H ;
Benomar, A ;
LyonCaen, O ;
Julien, J ;
Serdaru, M ;
Penet, C ;
Agid, Y ;
Brice, A .
ANNALS OF NEUROLOGY, 1996, 39 (04) :490-499
[9]   Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity [J].
Ellerby, LM ;
Andrusiak, RL ;
Wellington, CL ;
Hackam, AS ;
Propp, SS ;
Wood, JD ;
Sharp, AH ;
Margolis, RL ;
Ross, CA ;
Salvesen, GS ;
Hayden, MR ;
Bredesen, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) :8730-8736
[10]   MACHADO-JOSEPH-AZOREAN DISEASE - A 10-YEAR STUDY [J].
FOWLER, HL .
ARCHIVES OF NEUROLOGY, 1984, 41 (09) :921-925